BACKGROUND: The authors' laboratory previously demonstrated that long-term tolerance to class I-disparate renal allografts in miniature swine can be induced by a short course of cyclosporine A (CsA), and that this stable tolerance is dependent on the presence of an intact thymus. In the present study, the authors have examined the requirement for a thymus during the pretransplant, induction, and maintenance phases of tolerance. METHODS: Twenty-two miniature swine underwent class I major histocompatibility complex-mismatched renal transplantation, with a 12-day course of CsA. Thymectomies were performed on days -21, 0, +8, +21, and greater than or equal to +42, in relation to the day of transplantation. Historical controls consisted of euthymic and sham-thymectomized recipients. RESULTS: Euthymic, sham-thymectomized, and day-greater than or equal to +42 thymectomized recipients demonstrated stable renal function and minimal anti-donor cytotoxic T-lymphocyte (CTL) responses. In contrast, day -21 and day 0 thymectomized recipients demonstrated allograft dysfunction, marked cellular infiltrates, with severe vasculitis and glomerular changes, and strong anti-donor CTL responses. Animals thymectomized on days +8 and +21 did not undergo severe rejection, but likewise did not demonstrate a stable clinical course. CONCLUSIONS: These data indicate that the requirement for thymic function in the induction of rapid and stable tolerance is greatest during the first 8 days and then diminishes over the next 2 weeks posttransplant. Failure of thymectomy to affect the course of tolerance after day +21 suggests that thymic function is not required for the maintenance of tolerance. Understanding the role of the thymus in establishing tolerance may permit the development of tolerance induction strategies, especially for pediatric transplant recipients.
BACKGROUND: The authors' laboratory previously demonstrated that long-term tolerance to class I-disparate renal allografts in miniature swine can be induced by a short course of cyclosporine A (CsA), and that this stable tolerance is dependent on the presence of an intact thymus. In the present study, the authors have examined the requirement for a thymus during the pretransplant, induction, and maintenance phases of tolerance. METHODS: Twenty-two miniature swine underwent class I major histocompatibility complex-mismatched renal transplantation, with a 12-day course of CsA. Thymectomies were performed on days -21, 0, +8, +21, and greater than or equal to +42, in relation to the day of transplantation. Historical controls consisted of euthymic and sham-thymectomized recipients. RESULTS: Euthymic, sham-thymectomized, and day-greater than or equal to +42 thymectomized recipients demonstrated stable renal function and minimal anti-donor cytotoxic T-lymphocyte (CTL) responses. In contrast, day -21 and day 0 thymectomized recipients demonstrated allograft dysfunction, marked cellular infiltrates, with severe vasculitis and glomerular changes, and strong anti-donor CTL responses. Animals thymectomized on days +8 and +21 did not undergo severe rejection, but likewise did not demonstrate a stable clinical course. CONCLUSIONS: These data indicate that the requirement for thymic function in the induction of rapid and stable tolerance is greatest during the first 8 days and then diminishes over the next 2 weeks posttransplant. Failure of thymectomy to affect the course of tolerance after day +21 suggests that thymic function is not required for the maintenance of tolerance. Understanding the role of the thymus in establishing tolerance may permit the development of tolerance induction strategies, especially for pediatric transplant recipients.
Authors: Atsushi Hirakata; Masayoshi Okumi; Adam D Griesemer; Akira Shimizu; Shuji Nobori; Aseda Tena; Shannon Moran; Scott Arn; Richard L Boyd; David H Sachs; Kazuhiko Yamada Journal: Transpl Immunol Date: 2010-08-06 Impact factor: 1.708
Authors: Masayoshi Okumi; Jonathan M Fishbein; Adam D Griesemer; Pierre R Gianello; Atsushi Hirakata; Shuji Nobori; Shannon Moran; Emma Samelson-Jones; Akira Shimizu; David H Sachs; Kazuhiko Yamada Journal: Transplantation Date: 2008-01-27 Impact factor: 4.939
Authors: J R Scalea; M Okumi; V Villani; A Shimizu; H Nishimura; B C Gillon; R Torabi; T Cormack; S Moran; C LeGuern; D H Sachs; K Yamada Journal: Am J Transplant Date: 2014-08-06 Impact factor: 8.086
Authors: M Tasaki; V Villani; A Shimizu; M Sekijima; R Yamada; I M Hanekamp; J S Hanekamp; T A Cormack; S G Moran; A Kawai; D H Sachs; K Yamada Journal: Am J Transplant Date: 2016-06-13 Impact factor: 8.086
Authors: M Okumi; J R Scalea; B C Gillon; M Tasaki; V Villani; T Cormack; A Hirakata; A Shimizu; D H Sachs; K Yamada Journal: Am J Transplant Date: 2013-03-06 Impact factor: 8.086